The present invention provides pharmaceutical compositions formulated to include a statin and gemcabene, wherein the composition is useful for treating, preventing, or reducing the symptoms of cardiovascular and metabolic indications that involve elevate levels of LDL cholesterol, triglycerides, or both.
